crohn's disease and glp-1

crohn's disease and glp-1 Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review of receptor agonist efficacy safety GLP-1 with Crohn's Disease: Safety,

Name: crohn's disease and glp-1 Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review of receptor agonist efficacy safety GLP-1 with Crohn's Disease: Safety,
Brand: www.dakwerkencrul.be
SKU: 28201475083
Price: 28.41 USD
Availability: InStock
Rating: 4.612900000000001 (25 reviews)

SKU: 28201475083

4.6

EUR28.41 EUR66.41

Pay in 4 interest-free payments of $7.10 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

SGLT2 inhibitor users had the highest rates of hypertension and cardiovascular disease, whereas women prescribed GLP-1R agonists were more likely to be obese or suffer from polycystic ovarian syndrome (PCOS)

GLP-1 medications work by mimicking the GLP-1 hormone (a satiety-inducing hormone), which signals fullness to the brain, slows gastric emptying, and helps stabilize blood sugar, explains Dr